Skip to content

Exploring the Effects of Diazepam and Lorazepam

Exploring the Effects of Diazepam and Lorazepam on the Neural Correlates of Perceptual Priming and Explicit Memory in Healthy Volunteers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00696033
Acronym
ibid
Enrollment
22
Registered
2008-06-12
Start date
2007-07-31
Completion date
2008-12-31
Last updated
2025-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects

Keywords

Benzodiazepines, Lorazepam, Diazepam, Memory, Perceptual priming, Functional brain imaging, FMRI

Brief summary

Aims : * exploring lorazepam (0.038 mg/kg) effects, after a single oral intake, in healthy volunteers, on the neural correlates of encoding and retrieval of information during a word-stem completion task (implicit memory), using fMRI * comparing lorazepam effects to diazepam (0.3 mg/kg)effects * exploring benzodiazepines effects, after a single oral intake, on the neural correlates of successful encoding of information within explicit memory using fMRI Hypothesis : * both diazepam and lorazepam will impair explicit memory performance, but lorazepam only will impair perceptual priming * lorazepam and diazepam will modify the normal correlates of information encoding within explicit memory * lorazepam only will alter the neural correlates of perceptual priming

Interventions

DRUGDiazepam

Diazépam drug (0,3 mg/kg) on a single oral intake

DRUGLorazepam

Lorazépam drug (0,038 mg/kg) on a single oral intake

DRUGplacebo

lorazépam placebo or Diazépam placebo

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy subjects between 18 and 30 years * Students in medicine, dentistry or pharmacy * French as a mother language

Exclusion criteria

* Medical condition influencing brain function (neurological or psychiatric) * Asthma * General anesthesia in the 3 last months * Drug addiction (DSM IV criteria) * Regular medical treatment (except contraceptive pill) * Significant impairment observed during a medical examination including ECG * Intake of any psychotropic drug that can have a effect during testing * IQ (Wechsler) \< 100 * FMRI contra-indication (implantable magnetic material, claustrophobia) * Known allergy to benzodiazepine or lactose * \> 10 cigarettes/day * Pregnant or breast-feeding woman * No health insurance * Subjects who do not complete the entire study

Design outcomes

Primary

MeasureTime frame
Exploring lorazepam (0.038 mg/kg) effects, after a single oral intake, in healthy volunteers, on the neural correlates of encoding and retrieval of information during a word-stem completion task (implicit memory), using fMRIAfter a single oral intake

Secondary

MeasureTime frame
Comparing lorazepam effects to diazepam (0.3 mg/kg)effectsAfter a single oral intake
Exploring benzodiazepines effects, after a single oral intake, on the neural correlates of successful encoding of information within explicit memory using fMRIAfter single oral intake

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026